Article

Access to the text (HTML) Access to the text (HTML)
PDF Access to the PDF text
Advertising


Access to the full text of this article requires a subscription.
  • If you are a subscriber, please sign in 'My Account' at the top right of the screen.

  • If you want to subscribe to this journal, see our rates



Journal of the American Academy of Dermatology
Volume 57, n° 3
pages 428-434 (septembre 2007)
Doi : 10.1016/j.jaad.2007.02.036
accepted : 25 February 2007
Reports

The impact of total body photography on biopsy rate in patients from a pigmented lesion clinic
 

Jessica Risser, MD, MPH a, Zakiya Pressley, MD a, Emir Veledar, PhD b, Carl Washington, MD a, Suephy C. Chen, MD, MS a, c,
a From the Department of Dermatology 
b Center for Outcomes Research, Emory University 
c Department of Health Services Research and Development, Atlanta Department of Veterans Affairs Medical Center 

Reprint requests: Suephy C. Chen, MD, MS, Department of Dermatology, Emory University, 101 Woodruff Circle, Atlanta, GA 30322.

Atlanta, Georgia

Abstract
Background

Total body cutaneous photography is increasingly being used by dermatologists to monitor patients at risk for the development of melanoma, but limited evidence exists regarding the impact of such photography on melanoma and melanoma-related outcomes.

Objective

We sought to compare biopsy number in patients with multiple atypical nevi in their first year of care at our pigmented lesion clinic (PLC) between those who received total body skin examination alone and those who received total body skin examination and total body digital photography (TBDP). We sought to identify predictors of biopsy number and number of dysplastic nevi diagnosed in patients with multiple atypical nevi.

Methods

A chart review was performed of patients attending the PLC during the years 1998 to 2003 to identify the number of biopsies performed in the first year of care. Patient demographics, melanoma risk factors, and melanoma outcome events were also abstracted from the charts.

Results

The mean number of biopsies performed in patients in their first year of care at the PLC in those who did not receive TBDP was equal to the mean number of biopsies performed in patients who did receive TBDP (0.82 and 0.8, respectively). Linear regression analysis revealed that the interaction term between a lack of both personal history of melanoma and severe dysplastic nevi (−0.930, P = .005) has a significant protective effect on the number of biopsies. Similar regression analysis also showed that the interaction term between a lack of both personal history of melanoma and of severe dysplastic nevi (−1.209, P < .0001), increasing provider experience (−0.047, P = .029), and increased number of biopsies before the initial PLC (−0.028, P = .050) have a statistically significant protective effect on the number of dysplastic nevi diagnosed in the first year of PLC. TBDP did not have an effect on the number of biopsies or on the number of dysplastic nevi diagnosed in the first year of care at the PLC.

Limitations

This study is limited by being retrospective in nature, having a small sample size, and having a short follow-up period.

Conclusion

Overall, this small retrospective study does not provide evidence that would suggest that TBDP changes provider behavior in caring for patients at high risk for melanoma. Rather, our study supports the fact that a patient’s positive history of melanoma and a history of severe dysplastic nevi have the most significant impact on provider biopsy behavior, resulting in a lower threshold to biopsy suggestive lesions.

The full text of this article is available in PDF format.

 Drs Chen and Veledar are supported in part by a Mentored Patient Oriented Career Development Award (No. K23AR02185-01A1).
Conflicts of interest: None declared.
An abstract of this work was presented at the American Academy of Dermatology Annual Meeting, San Francisco, Calif, on March 4, 2006 and published in the poster abstract edition.



© 2007  American Academy of Dermatology, Inc.@@#104156@@
EM-CONSULTE.COM is registrered at the CNIL, déclaration n° 1286925.
As per the Law relating to information storage and personal integrity, you have the right to oppose (art 26 of that law), access (art 34 of that law) and rectify (art 36 of that law) your personal data. You may thus request that your data, should it be inaccurate, incomplete, unclear, outdated, not be used or stored, be corrected, clarified, updated or deleted.
Personal information regarding our website's visitors, including their identity, is confidential.
The owners of this website hereby guarantee to respect the legal confidentiality conditions, applicable in France, and not to disclose this data to third parties.
Close
Article Outline